Posted: October 13, 2012 - 12:01 am ET
Many hospitals will continue to use compounding pharmacies
for hard-to-obtain drugs because they have no alternative, even though a deadly
meningitis outbreak traced to a compounding facility has raised grave concerns
about safety and oversight.
As of Oct. 12, at least 184 people in 12
states had contracted fungal meningitis after receiving tainted steroid
injections from the New England Compounding Center, according to the Centers for
Disease Control and Prevention. Fourteen had died.
As a result, the Framingham, Mass.-based compounding pharmacy recalled more than 2,000 products
and shut down its operations. To continue reading click here
for hard-to-obtain drugs because they have no alternative, even though a deadly
meningitis outbreak traced to a compounding facility has raised grave concerns
about safety and oversight.
As of Oct. 12, at least 184 people in 12
states had contracted fungal meningitis after receiving tainted steroid
injections from the New England Compounding Center, according to the Centers for
Disease Control and Prevention. Fourteen had died.
As a result, the Framingham, Mass.-based compounding pharmacy recalled more than 2,000 products
and shut down its operations. To continue reading click here
No comments:
Post a Comment